ABSTRACT Four monoclonal antibodies to rat lung soluble guanylate cyclase [GTP pyrophosphate-lyase (cyclizing) EC 4.6.1.2] have been produced by fusing spleen cells from immunized BALB/ c mice with SP-2/0 myeloma cells. The antibodies were detected by their ability to bind immobilized guanylate cyclase and by immunoprecipitation of purified enzyme in the presence of second (rabbit anti-mouse) antibody. After subcloning by limiting dilution, hybridomas were injected intraperitoneally into mice to produce ascitic fluid containing 2-5 mg of antibody per ml. The four antibodies obtained had titers ofbetween 1:1580 and 1:3160 but were detectable at dilutions greater than 1:20,000. Soluble guanylate cyclase from several rat tissues were crossreactive with the four monoclonal antibodies, suggesting that the soluble enzyme from different rat tissues is antigenically similar. The antibodies also recognized soluble lung enzyme from rat, beef, and pig, while enzyme from rabbit was not crossreactive and mouse enzyme was recognized by only one of the antibodies. Particulate guanylate cyclase from a number of tissues had only minimal crossreactivity with the antibodies. Immunoprecipitated guanylate cyclase retained catalytic activity, could be activated with sodium nitroprusside, and was inhibited by cystamine. None of the antibodies were inhibitory under the conditions examined. These antibodies will be useful probes for the study of guanylate cyclase regulation and function under a variety of physiological conditions. Guanylate cyclase [GTP pyrophosphate-lyase (cyclizing) EC 4.6.1.2] catalyzes the formation of cyclic GMP from GTP. In all tissues examined, the enzyme exists in two forms, a membrane-bound form and a soluble form that has different properties. Work in many laboratories has also led to the finding that hydroxyl radical, hydrogen peroxide, nitric oxide, nitrosamines, and a variety of other nitro and nitroso compounds can activate both forms ofthe enzyme (for review, see ref. 1). Studies on the mechanisms ofthese activations have been hindered by the lack of highly purified preparations of the enzyme. However, the recent purification of the soluble enzyme from liver, lung, and brain (2-6) should permit detailed studies on protein structure and the mechanism of redox regulation of guanylate cyclase.
under various conditions and with immunohistochemical techniques. The development of highly specific antibodies to the enzyme could also be used for affinity purification procedures, guanylate cyclase turnover studies, and other experiments to examine the regulation and function of the enzyme and cyclic GMP. We have succeeded in obtaining four monoclonal antibodies to soluble guanylate cyclase; in this report, the production and characterization of these antibodies are described. Some ofthese observations have been reported as abstracts (11, 12) .
METHODS
Preparation of Tissue Homogenates. Tissues were removed from animals and 10% homogenates were prepared with 50 mM Tris HCl, pH 8/1 mM EDTA/1 mM dithiothreitoV250 mM sucrose in a Teflon homogenizer. The homogenates were centrifuged at 105,000 X g for 60 min at 2-4°C, and the supernatant and particulate fractions were stored at -700C.
Purification of Rat Lung Soluble Guanylate Cyclase. The details of the purification procedure have been published (6) . Briefly, the procedure involved isoelectric and ammonium sulfate precipitation, affinity chromatography on GTP-sepharose, and preparative polyacrylamide gel electrophoresis. This protocol led to preparations having specific activities of40-60 nmol mg'1 min-with Mg2e-GTP as substrate, which represents a purification of =3000-fold. The purified enzyme showed a single protein band on analytical isoelectric focusing and polyacrylamide gels that migrated coincident with enzyme activity and, under denaturing conditions, a single band of 72,000 daltons was obtained (6) .
Guanylate Cyclase Assay. Enzyme samples were incubated with 50 mM Tris HCl, pH 7.6/0.02% bovine serum albumin/ 1 mM GTP/4 mM MnCl2 or MgCl2 at 37°C for 10 min. With crude enzyme preparations, 10 mM theophylline/7.5 mM creatine phosphate/14 ,g of creatine phosphokinase (135 units/ mg) were included as described (7, 13) . Incubations were terminated with cold 50 mM NaOAc, pH 4, followed by boiling. Cyclic GMP formed was determined by radioimmunoassay (14 The ability of the four antibodies to crossreact with soluble guanylate cyclase from other rat tissues was investigated by immunoprecipitation of enzyme activity from crude supernatant fractions by using a second antibody as described above ( similar results, while antibody B3 gave less precipitation with all tissues tested. Antibodies B1, B2, and B4 resulted in a small activation of the enzyme from cerebral cortex, and somewhat less soluble enzyme from heart and testes preparations was precipitated compared with other tissues. These studies suggest, however, that the soluble enzymes from these rat tissues are antigenically quite similar. Crossreactivity of the antibodies toward soluble lung guanylate cyclase from other species was also examined by immunoprecipitation. All four antibodies crossreacted similarly with soluble lung enzyme from rat, beef, and pig (Table 2 ). There was a small activation of the beef and pig enzyme. None of the antibodies reacted with the rabbit enzyme. Antibodies B1, B2, and B3 showed some weak crossreactivity with mouse enzyme, while antibody B4 reacted more strongly, precipitating 60% of the activity. These studies suggest that the soluble lung enzyme from rat, pig, and beef are antigenically similar, while mouse and rabbit enzyme are different from each other and the other species examined. In addition, we have tested detergent-solubilized particulate guanylate cyclase from a number of tissues and found little or no crossreactivity with these antibodies.
The antibodies were also used to immunoprecipitate purified guanylate cyclase and examine the effects of sodium nitroprusside and cystamine on the precipitated antibody-bound enzyme (Table 3) . We found that, when guanylate cyclase was precipitated, the enzyme could be activated 6-to 9-fold with 100 uM sodium nitroprusside and inhibited almost completely by 2 mM cystamine. Thus, these observations are similar to our earlier reports with purified soluble enzyme (4, 6, 20) . These data suggest that, although all four antibodies are capable of binding to guanylate cyclase, the sites on the enzyme required for nitroprusside and nitric oxide activation and mixed disulfide inhibition are still accessible and presumably different from the antibody binding site. Ascites fluid was diluted 1:500 and incubated with 20 ng of purified guanylate cyclase from rat lung. After the addition of a second antibody, immune precipitates were collected, washed, and assayed for guanylate cyclase activity in the presence of sodium nitroprusside or cystamine using Mg2e-GTP as substrates.
DISCUSSION
Guanylate cyclase exists in two forms, a soluble and a particulate form, that differ in their kinetic characteristics, apparent size, and their relative abundance under some conditions (1) . It has been observed that, under conditions such as tumorigenesis or organ regeneration, there is an alteration in the intracellular distribution of the two enzyme forms such that the particulate becomes predominant (7-10). These studies have been compromised by the measurement of enzyme activity rather than of enzyme protein and would clearly be aided by specific antibodies capable ofdetecting and quantitating small amounts of the enzymes. Although the soluble form ofthe enzyme has been purified (2) (3) (4) (5) (6) , the particulate form has only recently been solubilized from membranes and partially purified (21, 22) . At present, the physicochemical relationship between the two enzyme forms is unknown.
Another area in the study of guanylate cyclase has been the regulation ofenzyme activity on an acute short-term basis. Considerable effort has failed to demonstrate any reproducible hormonal effects on the enzyme(s), although several naturally occurring agents have been shown to activate it. Fatty acids, the hydroxyl radical, and a wide variety of nitro and nitroso compounds are all capable ofactivating the enzyme, and the general theory that has emerged is one ofregulation ofguanylate cyclase by free radicals (1, 23) . The known involvement of free radicals in a number of biological, as well as pathological, events (24) makes this an interesting mechanism whereby cyclic GMP production may be coupled to cellular events. However, one major unanswered question has been the molecular changes that accompany such activations. Physicochemical studies of the enzyme to answer these and other related questions require larger quantities of purified enzyme than have been obtained with conventional purification methods.
In preparing to study some of the questions raised, we have sought to develop antibodies to soluble guanylate cyclase from rat lung. Although one group has recently reported low-titer antibodies to soluble brain guanylate cyclase in rabbits (5), the purified liver and lung enzyme in our hands have not proved to be very antigenic in rabbits or sheep for reasons that are currently unknown. This prompted us to consider production of antibodies in mice, with the eventual generation of mouse hybridomas secreting monoclonal antibodies. Such monoclonal antibodies have the marked advantage of being homogeneous and directed against a single antigenic determinant on the enzyme, be it a primary sequence or a three-dimensional conformation. It is obvious that a library of monoclonal antibodies, each to a different site, would be extremely useful in studying the types ofproblems described above. We have reported here on the successful fusion of mouse SP-2/0 myeloma cells with spleen cells from an immunized BALB/c mouse and on the characterization of four monoclonal antibodies to soluble guanylate cyclase from rat lung. After cell fusions and growth of hybridomas, the antibodies were detected by their ability to bind immobilized guanylate cyclase, followed by detection with '25I-labeled rabbit anti-mouse IgG. This method of screening was relatively fast, could accommodate large numbers of test hybridoma media, and positive clones were quite obvious. Once detected, the positive clones were selected for stability and subcloned by limiting dilution. Injection of the subeloned hybridomas into BALB/c mice led to the production of ascitic fluid containing 2-5 mg antibody per ml of ascitic fluid. Antibodies B1, B2, and B4 are of the IgG1 type, while B3 is an IgG2A. Monoclonal antibodies alone are nonprecipitating; however, when a second rabbit anti-mouse IgG antibody was included in incubation mixtures, the four antibodies were able to precipitate guanylate cyclase over a wide range of ascitic antibody dilution (1:100 to 1:10,000). Soluble guanylate cyclase from supernatant fractions of cerebral cortex, liver, heart, kidney, and testes homogenates also crossreacted with all four monoclonal antibodies with some small differences. Soluble lung enzyme from rat, pig, and beef reacted similarly with the antibodies, while lung enzyme from rabbit was nonreactive and mouse lung enzyme was partially reactive. All antibodies had only minimal reactivity with the particulate enzyme from several rat tissues. Although these studies suggest that soluble rat enzyme from several tissues is antigenically similar and different from rat particulate enzyme or the soluble enzyme of certain other species, additional studies are needed.
Although previous work has shown that guanylate cyclase can be activated by nitroso compounds, including azide, sodium nitroprusside, and nitric oxide (1, 4, 13) , the mechanism for this activation is unknown. In addition, we have recently reported on the reversible inhibition of guanylate cyclase on mixed disulfide formation with cystamine (20) . This work demonstrated the importance offree sulfhydryl groups for both basal and nitric oxide-activated enzyme activity (20) . In the present work, we have observed that, when guanylate cyclase is immunoprecipitated with these four monoclonal antibodies, the precipitated antibody-bound enzyme can be activated by nitroprusside and inhibited by cystamine. These data indicate that the site(s) responsible for these modulations of enzyme activity are not blocked by immunoprecipitation and must be different from the antibody-binding site.
The development of monoclonal antibodies to soluble guanylate cyclase should allow us to develop a number oftechniques to study questions concerning this enzyme and may help to elucidate the role(s) of cyclic GMP in biological systems.
